PULMATRIX
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSE™, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by achieving optimal local drug concentrations and reducing systemic side effects to improve patient outcomes.
PULMATRIX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.pulmatrix.com
Total Employee:
11+
Status:
Active
Contact:
(781)357-2399
Email Addresses:
[email protected]
Total Funding:
148.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Font Awesome Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - Pulmatrix
Polaris Partners
Polaris Partners investment in Post-IPO Equity - Pulmatrix
ARCH Venture Partners
ARCH Venture Partners investment in Post-IPO Equity - Pulmatrix
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Post-IPO Equity - Pulmatrix
5AM Ventures
5AM Ventures investment in Post-IPO Equity - Pulmatrix
Polaris Partners
Polaris Partners investment in Series B - Pulmatrix
5AM Ventures
5AM Ventures investment in Series B - Pulmatrix
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Pulmatrix
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Pulmatrix
5AM Ventures
5AM Ventures investment in Series B - Pulmatrix
Official Site Inspections
http://www.pulmatrix.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K
- Host name: 209.114.180.107.host.secureserver.net
- IP address: 107.180.114.209
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
